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Bluetongue is an insect-transmitted disease of sheep and wild ruminants that is caused by bluetongue virus (BTV). Cattle
are asymptomatic reservoir hosts of BTV. Infection of lung microvascular endothelial cells (ECs) is central to the pathogen-
esis of BTV infection of both sheep and cattle, but it is uncertain as to why sheep are highly susceptible to BTV-induced
microvascular injury, whereas cattle are not. Thus, to better characterize the pathogenesis of bluetongue, the transcription
of genes encoding a variety of vasoactive and inflammatory mediators was quantitated in primary ovine lung microvascular
ECs (OLmVECs) exposed to BTV and/or inflammatory mediators. BTV infection of OLmVECs increased the transcription of
genes encoding interleukin- (IL) 1 and IL-8, but less so IL-6, cyclooxygenase-2, and inducible nitric oxide synthase. In
contrast, we previously have shown that transcription of genes encoding all of these same mediators is markedly increased
in BTV-infected bovine lung microvascular ECs and that BTV-infected bovine ECs produce substantially greater quantities of
prostacyclin than do sheep ECs. Thus, sheep and cattle were experimentally infected with BTV to further investigate the role
of EC-derived vasoactive mediators in the pathogenesis of bluetongue. The ratio of thromboxane to prostacyclin increased
during BTV infection of both sheep and cattle, but was significantly greater in sheep (P  0.001). Increases in the ratio of
thromboxane to prostacyclin, indicative of enhanced coagulation, coincided with the occurrence of clinical manifestations of
bluetongue in BTV-infected sheep. The data suggest that inherent species-specific differences in the production and activities ofINTRODUCTION
Bluetongue is an insect-transmitted virus disease
of sheep and wild ruminants that is characterized by
manifestations of microvascular injury, including pulmo-
nary edema, disseminated intravascular coagulation
(DIC), and vascular thrombosis with tissue infarction
(MacLachlan, 1994; Mahrt and Osburn, 1986; Moulton,
1961; Pini, 1976; Spruell, 1905). In contrast, bluetongue
virus (BTV) infection of cattle is typically asymptomatic,
and cattle function as reservoir hosts of BTV (Barratt-
Boyes andMacLachlan, 1995; MacLachlan, 1994). Sporadic
occurrence of disease in BTV-infected cattle has been
attributed to an IgE-mediated hypersensitivity reaction
(Anderson et al., 1987). It is uncertain as to why BTV
infection causes extensive microvascular injury in sheep
but not cattle, as the cell and tissue tropism of BTV is
similar in the two species. Specifically, BTV replicates
principally in endothelial cells (ECs) and mononuclear
phagocytic cells in the lungs and lymphoid tissues of
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330both sheep and cattle (Barratt-Boyes and MacLachlan,
1994, 1995; Barratt-Boyes et al., 1995; MacLachlan et al.,
1990; Pini, 1976).
Coen et al. first proposed that species-specific differ-
ences in EC infection and cytokine production are re-
sponsible for the different clinical outcomes of BTV in-
fection of cattle and sheep (Coen et al., 1991). Subse-
quent studies confirmed that cytolysis and interferon
production were different in BTV-infected ovine and bo-
vine umbilical vein ECs (Russell et al., 1996), and we
recently demonstrated that the mechanism of cell death
(apoptosis or necrosis), infection kinetics, and the pro-
duction of prostacyclin all differed between BTV-infected
ovine and bovine pulmonary artery and lung microvas-
cular ECs (DeMaula et al., 2001). A variety of inflamma-
tory mediators are produced in response to virus infec-
tions, and those released from activated ECs that mod-
ulate vasomotor tone, thrombosis, and/or inflammation
include nitric oxide, prostacyclin, interferons, interleukin
1 (IL-1), IL-6, and chemokines such as IL-8 (Cotran et al.,
1999; Mantovani et al., 1992; Moncada et al., 1990). Pros-
tacyclin may have an especially important role in deter-
mining the outcome of BTV infection of ruminants be-
cause it is a potent vasodilator and inhibitor of plateletEC-derived mediators contribute to the sensitivity of sheep to
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aggregation that is produced primarily by ECs (DeMaula
et al., 2001; Moncada and Amezcua, 1979).BTV-in
ttle; sh
To further characterize the central role of inflammatory
mediators in the pathogenesis of BTV-induced microvas-
cular injury, we evaluated the responses of pure cultures
of primary ovine lung microvascular ECs (OLmVECs) to
BTV infection and/or treatment with inflammatory medi-
ators and compared the responses of OLmVECs to those
of bovine lung microvascular ECs (DeMaula et al., 2002).
We also compared levels of prostacyclin and thrombox-
ane in the plasma of experimentally infected sheep and
cattle to investigate the potential role of these potent
vasoactive mediators in the pathogenesis of bluetongue.
RESULTS
BTV-induced transcription of genes encoding
inflammatory and vasoactive mediators in OLmVECs
OLmVECs were highly susceptible to infection with
either purified BTV or a lysate of BTV-infected OLmVECs
(BTV/OLmVEC lysate) that contained both BTV and virus-
induced EC-derived mediators, and cytopathic effect was
complete (95%) within 36 h after infection of the cul-
tures (data not shown). High titers of BTV were present at
24 h after infection of OLmVECs with either purified BTV
or the BTV/OLmVEC lysate (Fig. 1). The concentration of
IL-1 mRNA was significantly increased (P  0.024) in
OLmVECs infected with purified BTV, whereas infection
of OLmVECs with the BTV/OLmVEC lysate did not in-
crease the transcription of IL-1 mRNA (Fig. 1). The con-
centration of IL-8 mRNA was significantly increased in
OLmVECs infected with either purified BTV (P  0.05) or
the BTV/OLmVEC lysate (P  0.047), although IL-8
mRNA concentrations were lower in OLmVECs infected
with the BTV/OLmVEC lysate than in OLmVECs infected
with purified BTV. Infection with either purified virus or
the BTV/OLmVEC lysate induced only minimal increases
in IL-6 mRNA in OLmVECs. Treatment of OLmVECs with
a mixture of BTV-induced-EC-derived inflammatory me-
diators (virus-free) did not significantly increase tran-
scription of mRNAs encoding any of the cytokines mea-
sured, and only IL-8 mRNA was significantly increased in
OLmVECs treated with the cocktail of recombinant cyto-
kines (P  0.035).
BTV infection did not significantly increase the tran-
scription of genes encoding either COX-2 or iNOS, en-
zymes that respectively function in the biosynthetic path-
ways of prostacyclin and nitric oxide. Similarly, treatment
of OLmVECs with a mixture of BTV-induced-EC-derived
inflammatory mediators (virus-free) did not significantly
increase the concentration of COX-2 and iNOS mRNAs,
and the cocktail of recombinant cytokines (positive con-
trol) induced only a very transient increase in COX-2
mRNA (P  0.036) at 6 h after infection.
Mock-infected OLmVECs expressed only low levels of
mRNAs encoding inflammatory and vasoactive media-
tors, confirming the specificity of the responses of the
OLmVECs to BTV infection and/or exposure to inflamma-
tory mediators.
The ratio of plasma thromboxane to prostacyclin is
higher in BTV-infected sheep than in cattle
Sheep infected with BTV by the bites of Culicoides
sonorensis developed pyrexia, lethargy, and tachypnea
and one had an intermittent pleural friction rub between
7 and 11 days postinfection (d.p.i.), whereas infected
cattle developed only transient and mild pyrexia (Table
1). BTV was first isolated from the blood of infected
sheep at 5 d.p.i. and from the blood of cattle at 7 to
14 d.p.i. All animals seroconverted to BTV by 14 d.p.i. as
determined by competitive enzyme-linked immunosor-
bent assay (cELISA; data not shown). Plasma thrombox-
ane concentrations were significantly increased in
sheep between 7 and 11 d.p.i. (P  0.007), and in cattle
at 9 and 11 d.p.i. (P  0.009), as compared to levels at
0 d.p.i. (Fig. 2). Plasma prostacyclin concentrations pro-
gressively increased through 21 d.p.i. in cattle, whereas
the concentration of prostacyclin decreased significantly
after 7 d.p.i. in sheep (P  0.002) and did not return to
baseline levels by 21 d.p.i. The ratio of thromboxane to
prostacyclin increased during BTV infection of both
sheep and cattle, but was significantly greater (P 
0.001) in sheep at 9 d.p.i. The increased ratios of throm-
boxane to prostacyclin also coincided with the occur-
rence of pyrexia and maximal viremia in both BTV-in-
fected sheep and cattle (Table 1). Uninfected control
animals remained seronegative to BTV, and the concen-
tration of plasma prostacyclin and thromboxane was
constant over the 21-day period (data not shown).
Five additional sheep were infected with BTV by direct
subcutaneous and intravenous inoculation to confirm the
influence of BTV infection on prostacyclin production in
sheep. These sheep developed relatively mild clinical
signs of blue tongue that included fever, nasal discharge,
inappetence, depression, tachypnea, and intermittent
lameness between 10 and 21 d.p.i., and all animals
seroconverted to BTV between 7 and 14 d.p.i. as deter-
mined by cELISA (data not shown). Plasma prostacyclin
concentrations of these sheep also decreased signifi-
cantly between 11 and 21 d.p.i. (P  0.011), although the
decline occurred 4 days later than in sheep infected with
BTV by the bites of C. sonorensis insects (data not
shown).
DISCUSSION
The highly purified cultures of sheep ECs used in this
study provide a convenient, reproducible, and relevant in
vitro model with which to evaluate the pathogenesis of
bluetongue. We previously described differences in the
response of ovine and bovine lung microvascular ECs to
BTV infection (DeMaula et al., 2001), and data from the
present study further confirm that there are marked spe-
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cies-specific differences in the production of inflamma-
tory (IL-1, IL-6, and IL-8) and vasoactive (COX-2 and
iNOS) mediators by BTV-infected ruminant ECs. Specifi-
cally, although infection of OLmVECs with purified BTV
resulted in markedly increased transcription of IL-1
mRNA, responses typically induced by IL-1, such as pro-
duction of IL-6 and vasoactive mediators, were minimal
in BTV-infected OLmVECs as compared to those we
previously described in BTV-infected bovine lung micro-
vascular ECs (DeMaula et al., 2002). In further contrast to
bovine lung microvascular ECs, IL-1 mRNA was not in-
creased in OLmVECs infected with the BTV/OLmVEC
lysate, indicating that BTV-induced EC-derived cytokines
likely suppress the production of some proinflammatory
mediators in OLmVECs. We also previously reported that
bovine ECs produced significantly higher levels of pros-
tacyclin after BTV infection than did OLmVECs (DeMaula
et al., 2001), which is consistent with the minimal in-
crease in COX-2 mRNA that occurred in BTV-infected
OLmVECs in the present study. Prostacyclin and nitric
FIG. 1. The responses of ovine lung microvascular endothelial cells to infection with bluetongue virus and/or treatment with inflammatory mediators.
Cellular responses were evaluated by measuring the concentrations of mRNAs encoding cytokines (IL-1, IL-6, and IL-8) and enzymes that synthesize
prostaglandins (cyclooxygenase-2) or nitric oxide (inducible nitric oxide synthase). The concentrations of mRNA are expressed as n-fold increases
relative to mRNA expressed in mock infected cells (M, untreated control).
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oxide are potent vasodilators and antithrombotic agents
that may counter the prothrombotic effects of IL-1 and
subendothelial extracellular matrix exposed by cytolysis
of ECs, as likely occurs during BTV infection (DeMaula et
al., 2001; Mantovani et al., 1992; Cotran et al., 1999). Thus,
these in vitro data are consistent with the sensitivity of
sheep and resistance of cattle to BTV-induced microvas-
cular injury and thrombosis, DIC, and hemorrhagic dia-
thesis.
Prostanoids are central to the pathogenesis of a vari-
ety of vascular diseases. Continuous infusion of prosta-
cyclin normalizes plasma markers of EC injury and plate-
let aggregation in primary pulmonary hypertension of
humans for example (Friedman et al., 1997), and plasma
prostacyclin and thromboxane levels are increased in
human patients with acute myocardial infarction (Gurbel
et al., 1999). Similarly, prostacyclin modulates vaso-
spasm of bovine coronary arteries (Zou and Bachschmid,
1999; Zou et al., 1999a,b), and sheep with chronic lung
injury that were treated with interferon- developed pul-
monary hypertension that was correlated with increases
in plasma levels of thromboxane. Treatment of these
sheep with a specific thromboxane synthase inhibitor
blocked the hypertensive effects of interferon-
(Hanaoka et al., 1999). Data from the present study
strongly suggest that the relative concentrations of
plasma prostanoids also may determine the outcome of
BTV infection of ruminants. Specifically, the decrease in
plasma concentrations of prostacyclin in sheep is con-
sistent with the minimal transcription of COX-2 mRNA in
OLmVECs, and the most pronounced changes in plasma
prostanoid concentrations coincided with the occur-
rence of clinical signs and maximal viremia in BTV-
infected sheep. The significantly greater increase in the
ratio of thromboxane to prostacyclin in the blood of
BTV-infected sheep as compared to cattle is also con-
sistent with the occurrence of DIC that characterizes
bluetongue.
In summary, differences in the production of vasoac-
tive and inflammatory mediators in BTV-infected ovine
and bovine lung microvascular ECs parallel the different
clinical consequences of BTV infection of sheep and
cattle. Furthermore, the ratio of plasma thromboxane to
prostacyclin, an indicator of enhanced coagulation, is
significantly greater in BTV-infected sheep than in cattle.
Inherent species-specific differences in BTV-induced
production of EC-derived inflammatory and vasoactive
mediators may, therefore, determine the susceptibility of




The isolation, cultivation, and purification of OLmVECs
previously have been described in detail (DeMaula et al.,
2001). Briefly, primary cultures of OLmVECs were derived
from yearling sheep by enzymatic digestion of lung tis-
sue followed by fluorescence-activated cell sorting until
completely pure cultures were obtained. The identity and
TABLE 1
Viremia and Pyrexia in BTV-Infected Sheep and Cattle
DPI Preinfection 1 3 5 7 9 11 14 21
Calf 1
Virus Isolation nd — — —     
Temp. (°F) 102.1 101.6 102.4 101.6 103.4 101.6 101.6 103.8 102.1
Calf 2
Virus Isolation — — — — —    
Temp. (°F) 102.0 102.4 102.0 102.8 101.8 101.6 102.5 102.3 101.8
Calf 3
Virus Isolation — — — — — nd nd  
Temp. (°F) 101.8 102.0 101.8 102.3 102.5 nd nd 103.2 102.2
Sheep 1
Virus Isolation — — —     — —
Temp. (°F) 103.0 103.6 103.0 103.0 105.5 106.1 104.0 103.0 102.6
Sheep 2
Virus Isolation — — —     — —
Temp. (°F) 103.8 103.1 103.0 102.8 103.8 104.5 103.2 102.5 102.5
Sheep 3
Virus Isolation — — —     — —
Temp. (°F) 102.3 nd 104.3 104.4 105.7 104.4 102.8 104.0 102.5
Note. All animals seroconverted by 14 days postinoculation (DPI); nd  not done.
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FIG. 2. Concentrations of thromboxane and prostacyclin in the plasma of sheep and cattle infected with bluetongue virus by the bites of Culicoides
sonorensis.
334 DEMAULA ET AL.
purity of the cultures were confirmed by immunohisto-
chemical staining with a panel of antibodies to EC-
specific markers. OLmVECs maintain their phenotype in
culture (Meyrick et al., 1991), thus low passage stocks
were cryopreserved and used between passages 7 and
15 in all experiments.
Virus
A strain of BTV serotype 17 in the blood of a sheep that
died of naturally acquired bluetongue was passaged
twice in seronegative cattle. The virus was then isolated
from cattle blood in primary bovine lung microvascular
ECs and purified as previously described (DeMaula et
al., 2001). OLmVECs then were infected with partially
purified BTV to produce the virus stock that was used in
this study. The BTV-infected OLmVECs were frozen at
70°C, thawed, homogenized, and sonicated, and the
titer (TCID50) of the virus stock was then determined by
microtiter assay as described (Barratt-Boyes et al., 1992;
MacLachlan et al., 1984). This lysate (BTV/OLmVEC ly-
sate) contained both BTV- and EC-derived inflammatory
mediators that were induced by virus infection. A par-
tially purified BTV inoculum was also derived from this
BTV/OLmVEC lysate, but virus was separated from the
mediators contained in the lysate by ultracentrifugation
through sucrose as described previously (DeMaula et al.,
2001).
BTV infection of OLmVECs
OLmVEC cultures of similar passage and cell density
were infected at 6-h intervals with either partially purified
BTV or the BTV/OLmVEC lysate (virus and mediators) at
a multiplicity of infection (m.o.i.) of 0.5 to 1. Control mono-
layers were inoculated (mock infected) with culture me-
dium or a lysate of uninfected OLmVECs also at 6-h
intervals. The cytopathic effect in the various OLmVEC
cultures was estimated at 6-h intervals as a percentage
of the monolayer, and the cells in each culture were then
prepared simultaneously for virus titration and TaqMan
real-time polymerase chain reaction (PCR) assay for
quantitation of mRNAs encoding a variety of mediators.
Culture media from each flask was clarified by centrifu-
gation at 400 g. Cells remaining in each flask were
removed nonenzymatically with 0.05 M EGTA in Hank’s
balanced salt solution, pooled with those previously pel-
leted from the media, and washed once with phosphate-
buffered saline (PBS). Portions of the clarified media and
cells collected from the various cultures were combined
and the titer of BTV was determined by microtitration in
BHK-21 cells as previously described (Barratt-Boyes et
al., 1992; MacLachlan et al., 1984).
Treatment of OLmVECs with inflammatory mediators
BTV-induced EC-derived inflammatory mediators were
harvested from the lysate of BTV-infected OLmVECs as
the supernatant after virus was removed by ultracentrif-
ugation. Uninfected OLmVEC cultures of similar passage
and cell density were treated at 6-h intervals with the
mixture of BTV-induced OLmVEC-derived inflammatory
mediators or with a cocktail of recombinant cytokines
that included murine IL-1 (10 ng/ml; Sigma), murine
tumor necrosis factor  (TNF, 1.64 ng/ml; Sigma), and
platelet activating factor (PAF, 1 mM; Sigma). Murine
IL-1 and TNF activate human and ruminant ECs (Bar-
gatze et al., 1994; DeMaula et al., 2002; Jutila et al., 1994;
Meyrick et al., 1991) and synergistically interact with PAF
(DeMaula et al., 2001; Sterner-Kock et al., 1996).
Quantitation of cytokine, COX-2, and iNOS mRNAs in
OLmVECs
The TaqMan real-time PCR procedures for the quan-
titation of bovine IL-1, IL-6, and IL-8; cyclooxygenase-2
(COX-2); and inducible nitric oxide synthase (iNOS) mR-
NAs have been previously described (Collins et al., 1999;
DeMaula et al., 2002; Leutenegger et al., 2000; Leuteneg-
ger et al., 1999a,b). The TaqMan real-time PCR assays
used for the quantitation of ovine IL-1, IL-6, IL-8; iNOS;
and COX-2 mRNAs were identical to those described for
the equivalent bovine molecules with the exception of
the IL-8 assay, which was optimized using the same
procedures (Table 2). Primers and probes were designed
with the PrimerExpress software package (Applied Bio-
systems) such that the probe spanned the junction of two
exons covered by the primers, ensuring discrimina-
tion between genomic DNA and cDNA generated from
mRNAs. Approximately 2  106 ECs were collected at
each 6-h treatment interval, pelleted from the PBS wash,
and stored at70°C. The frozen cells were lysed in lysis
buffer and total RNA was extracted using the RNeasy Kit
(Qiagen) according to the manufacturer’s instructions.
The extracted RNA was treated with DNase I and reverse
transcribed with SuperScript II reverse transcriptase
(Life Technologies). The primers, probe, PCR master-mix,
and AmpErase UNG were combined with the cDNA de-
rived from each 6-h sample and amplified in an auto-
mated fluorometer (ABI Prism 7700 sequence detection
system; Applied Biosystems). Cytokines, COX-2, and
iNOS mRNAs were quantitated by the comparative cycle
threshold (C T) method. Mock-infected samples were
used as the reference sample (calibrator) for each me-
TABLE 2





a Abbreviations: f, forward primer; r, reverse primer; p, probe.
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diator. The relative change in mRNA concentration (C T)
for each mediator was then determined from the differ-
ence between the calibrator C T and the C T for each
mediator in the OLmVECs treated with the various
inocula.
Statistical analysis
All experiments were repeated at least once and the
data from replicate experiments were compared at var-
ious intervals after inoculation. The MINITAB (Minitab
Inc.) software package was used to calculate the mean
values and standard deviations for each parameter and
Student’s t test was applied to determine differences
between mean values of the data at each time point, with
P  0.05 considered significant. The comparison yield-
ing the highest P value0.05 is reported in cases where
multiple t tests were used to identify statistical differ-
ences.
Determination of plasma levels of thromboxane and
prostacyclin in BTV-infected sheep and cattle
Yearling mixed-breed sheep and yearling Holstein or
Angus-cross steers that were seronegative to BTV, as
determined by cELISA (DiagXotics), were obtained from
a BTV-free region of California. Three sheep and three
steers were each infected by the bites of BTV-infected
Culicoides insects, and five additional sheep were in-
fected by direct inoculation of 1.0 ml of infected blood (0.5
ml subcutaneously and 0.5 ml intravenously) that con-
tained approximately 103.5 TCID50 of BTV. The animals
were infected with the same strain of BTV serotype 17
used in the in vitro studies. One sheep and one steer
were mock-infected by the feeding of uninfected insects
(negative controls). The insects used for infection of
cattle and sheep were reared and infected with BTV as
previously described (Bonneau et al., 2001). Briefly, a
laboratory colony of C. sonorensis was established from
a susceptible field population (Gerry et al., 2001; Mullens
et al., 1995). One- to 4-day-old adult insects were fed
sheep blood through a thin Parafilm membrane. Insects
used to infect the sheep and cattle were fed blood
spiked with partially purified BTV to a titer of 107.13 TCID50/
ml, and control insects were fed uninfected ruminant
blood. Engorged insects were held at 27°C for an extrin-
sic incubation period of 10 days. Surviving females (ap-
proximately 50) and a few males were placed in a hold-
ing cage affixed to a shaved area of the animal’s thorax
and allowed to feed through a nylon mesh stocking for
1 h.
Blood was collected from individual animals every
other day and processed as previously described (Dray
et al., 1975). Briefly, 10-ml Vacutainer tubes containing
0.95 ml of a 2% disodium EDTA/0.8% NaCl solution (pH
7.4) and 0.05 ml of a 40 mM indomethacin solution were
prechilled on ice. Blood was collected from the jugular
vein, mixed with the anticoagulant and cyclooxygenase
inhibitor, and immediately placed on ice. The plasma
was harvested by centrifugation at 4°C and stored at
20°C within 1 h of collection. Plasma samples were
thawed only once, and the prostanoids from 1 ml of ovine
or bovine plasma were extracted by reverse-phase chro-
matography using an Amprep Ethyl C2 column (Amer-
sham). Dried samples were resuspended to original vol-
ume (1 ml) in assay buffer and the concentrations of
6-keto-prostaglandin 1 (stable metabolite of prostacy-
clin) and thromboxane B2 (stable metabolite of thrombox-
ane A2) were determined by cELISA according to the
manufacturer’s instructions (Amersham). Prostacyclin
and thromboxane concentrations were determined from
a minimum of two measurements from each animal at
each time point. The MINITAB (Minitab Inc.) software
package was used to calculate the mean values and
standard deviations for each measurement, and Stu-
dent’s t test was applied to determine differences be-
tween mean values of the data at each time point, with
P  0.05 considered significant. The comparison yield-
ing the highest P value is reported where multiple t tests
were used.
Virus isolation from cattle and sheep blood was done
as previously described (Bonneau et al., 2001). Briefly,
ACD Vacutainer tubes containing blood collected at the
same time as the prostanoid samples were centrifuged,
and the blood cells were washed three times with sterile
phosphate-buffered saline. Confluent monolayers of BHK
cells in 24-well plates were inoculated with serial 10-fold
dilutions of washed, lysed blood cells and incubated at
37°C for 10 days. Cultures that did not exhibit cytopathic
effect were passaged a second time. Cytopathic agents
isolated from ruminant blood were confirmed as BTV by
immunofluorescent staining of infected monolayers of
BHK cells grown on chamber slides using a fluorescein
isothiocyanate-labeled monoclonal antibody to BTV core
protein VP7 (Whetter et al., 1989).
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